ReviewCardiovascular endocrinology2017
Pioglitazone and cardiovascular risk reduction: time for a second look?
Ana L Perdigoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewCardiovascular endocrinology2017
Ana L Perdigoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.